Sources of Funding
NNF, Johnsen
The trial was funded by the Novo Nordic Foundation (NNF) 170C0029520. Dr Simonsen received grants from the NNF and Health Research Foundation of central Denmark region. Dr Johnsen received grants from Pfizer and NNF.